Drug therapies in chronic heart failure: a focus on reduced ejection fraction
Helena Bolam, Geraint Morton and Paul R Kalra
DOI: https://doi.org/10.7861/clinmedicine.18-2-138
Clin Med April 2018 Helena Bolam
ADepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Roles: cardiology specialist registrar
Geraint Morton
BDepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Roles: consultant cardiologist
Paul R Kalra
CDepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Roles: consultant cardiologist
Article Information
vol. 18 no. 2 138-145
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online April 6, 2018.
Copyright & Usage:
© Royal College of Physicians 2018. All rights reserved.
Author Information
- Helena Bolam, cardiology specialist registrarA,
- Geraint Morton, consultant cardiologistB and
- Paul R Kalra, consultant cardiologistC
- ADepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
- BDepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
- CDepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
- Address for correspondence: Dr Paul R Kalra, Department of Cardiology, Portsmouth Hospitals NHS Trust, Southwick Hill Road, Cosham, Portsmouth PO6 3LY, UK. Email: paulkalra{at}doctors.org.uk
Article usage
Article Tools
Drug therapies in chronic heart failure: a focus on reduced ejection fraction
Helena Bolam, Geraint Morton, Paul R Kalra
Clinical Medicine Apr 2018, 18 (2) 138-145; DOI: 10.7861/clinmedicine.18-2-138
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Introduction
- Established prognostic therapy in HFrEF
- Newer agents with prognostic benefit
- Diuretics
- Older therapies with some prognostic benefit
- Drugs with little or no prognostic benefit
- Considerations in specific situations
- Systems of care for optimising drug therapy
- The future
- Drug therapies in HFpEF/HFmrEF
- Drug therapies in the prevention of heart failure
- Conclusion
- Conflicts of interest
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.